Accriva HEMOCHRON Jr. ACT–LR

מדינה: סינגפור

שפה: אנגלית

מקור: HSA (Health Sciences Authority)

זמין מ:

BIOMED DIAGNOSTICS PTE LTD

סיווג:

Class C IVD

תוצרת:

Accriva Diagnostics Inc.

איזור תרפויטי:

Hematology

סממני תרפויטית:

The HEMOCHRON® Jr. ACT–LR is a quantitative assay for monitoring heparin anticoagulation during various medical procedures. The ACT–LR demonstrates linear correlation to the anticoagulation effects of heparin up to 2.5 units/ml of blood. It is intended for use in monitoring low to moderate heparin doses frequently associated with procedures such as cardiac catheterization, Extracorporeal Membrane Oxygenation (ECMO), hemodialysis, and Percutaneous Transluminal Coronary Angioplasty. (The HEMOCHRON Jr. ACT+ [JACT+] test is available for monitoring moderate to high levels [1-6 units/ml] of heparin.) The ACT–LR test is performed on any HEMOCHRON Jr. model using a fresh whole blood sample. Each instrument is portable and is intended for bedside use. The instrument is not intended for home use.

leaflet_short:

Models: Hemochron Jr. Signature Plus Whole Blood Coagulation System - PSIG, Hemochron ACT-LR Cuvettes - JACT-LR, directCHECK Whole Blood Control - DCJLR-N, directCHECK Whole Blood Control - DCJLR-A

תאריך אישור:

2011-11-09